acebutolol has been researched along with Uremia in 1 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decourt, S | 1 |
| Roux, A | 1 |
| Baglin, A | 1 |
| Domart, M | 1 |
| Aubert, P | 1 |
| Flouvat, B | 1 |
| Fritel, D | 1 |
1 other study available for acebutolol and Uremia
| Article | Year |
|---|---|
[Study of the binding of beta blockers to plasma proteins. Therapeutic consequences].
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Proteins; Dose-Response Relationship, Drug; Humans; H | 1977 |